Q&A with Karin de Visser.

Karin de Visser is senior group leader at the Division of Tumor Biology & Immunology at the Netherlands Cancer Institute.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 In this interview with Cell Reports Medicine, Karin de Visser talks about her journey in science and shares her insights about tumor microenvironment modulation to improve patient therapies.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: